Jun. 18 at 11:21 AM
$EVH Little brain in action, quote.
In reality, Evolent Health is just undergoing a radical change in its internal strategy and should show enormous progress as early as next year. Debt will be high, but that doesn't change the fact that Evolent is capable of signing deals totaling
$1 billion a year without any problems. By the time they secure other significant deals, we'll already be talking about net profits.
A company with
$3.5 billion in revenue next year and thousands of employees will be closely monitored by competitors and banks for acquisitions.
Ps. Road to 10$ soon, very soon
